期刊文献+

Graves病患者外周血sIL-2R和TRAb水平的临床研究

Clinical study on soluble interleukin-2 receptor(sIL-2R) and thyrotropin receptor antibody(TRAb)in Graves' disease
全文增补中
导出
摘要 目的:观察Graves病患者治疗前后sIL-2R和TRAb水平的变化,指导临床用药及监测病清。方法;分别应用酶联法检测Graves病患者治疗前后及对照组外周血sIL—2R和TRAb,用放射免疫法测定T4、T3,并比较其变化。结果:Graves病患者治疗前血sIL—2R和TRAb水平明显高于治疗后及正常对照组,并且二者均与T4、T3水平呈正相关。结论:监测外周血sIL—2R和TRAb水平对于Graves病患者的治疗及预后分析有着重要意义。 Objective: To study the changes of sIL -2R and TRAb levels in patients with Graves' disease and clarify their roles in monitroing the patients. Methods: sIL --2R and Trab were measured by ELISA, T3 and T4 were asssessed by radioimunoassay. Results:The levels of sIL -2R and TRAb in GD patients were higher than that in euthyroid patients and the controls. Significantly positive correlations were observed between sIL -2R .TRAb and T3.T4. Conclusion: The measurements of serum sIL -2R and TRAb may be very important to prognostic purposes and the patients' immunological status.
出处 《河北职工医学院学报》 2000年第1期20-23,共4页 Journal of Hebei Medical College for Continuing Education
关键词 SIL-2R 患者 GRAVES病 外周血 治疗前后 对照组 临床研究 水平 结论 指导 Graves' disease Soluble interleukin-2 eceptor(sIL-2R) Thyrotropin receptor antibody(TRAb)
  • 相关文献

参考文献17

  • 1Laurence A, Rubin, M. D, Nelson D.L.Thesouble Inter leukin-2 Receptor: Biology, Function and Dinincal Appli cation. Ann Intern Med, 1990, 113:619.
  • 2王德全,王秀问,任建民,王洁贞,李玉芳,王宜民,韩效才.甲状腺疾病患者血清可溶性白细胞介素2受体测定的临床意义[J].中国免疫学杂志,1995,11(1):60-62. 被引量:3
  • 3Koukkou E, Panayiotidis P, Alevizou-Teraki V,et al.High levels of serum soluble interlenkin-2 recepter in hyperthyroid patients:correlation with serum thyroid horenes and independence from the etiology of the hypethyroidism.J Clin Zndocrinol Metab, 1991,73(4) :771.
  • 4Marriotti S, C. atnreg Li G,Barbesino M,et al, Thyroid function andthyroid antoimmunity independently modnlate serum concentration of soluble interlenkin-2 receptor(slL-2R)in thyroid disease. ClinZndocrinol, 1992,37:415.
  • 5任跃忠,宋作圭.Graves病与血清可溶性白细胞介素2受体的关联研究[J].中华医学杂志,1993,73(5):264-265. 被引量:1
  • 6Chow C C, Lai K N, Leung J C K,et al.Serum soluble interlenkin-2 receptor in hyperthyroid Graves' disease and effect of carbimazle therapy. Clin Endocrind, 1990,38:317.
  • 7Nakanishi K, Taniguchi Y, Ohta y. Increased soluble interlenkin 2 receptor levels in antoimmnne thyroid disease.Acta Endocrinol Copenh, 1991,125:253.
  • 8刘建民,吴万龄,朱炳法,谢冠群,洪金秧.Graves病患者IL-2/IL-2R系统的改变[J].中华内分泌代谢杂志,1996,12(1):20-22. 被引量:11
  • 9Burch H B, Sellitti D, Barnes S G, et al. Thyrotropin recepor antiera for the detection of immunoreactive protein species in retroocnlar fibroblasts obtained for patients with Graves'ophthalmopathy. J ClinEndocrinol Metab, 1994, 78(6):1384.
  • 10Ilicki A, Gamstedt A, Karlsson FA,et al. Hyperthyroid Graves'disease without detectable thyrotropin receptor antibodies.J ClinEndocinol Metab, 1993,74(5):1090.

二级参考文献3

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部